Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02247960 · ClinicalTrials.gov registry record · NA

Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy

A NA study, sponsored by University of Rochester.

Terminated
Registry status
NA
Development phase
175
Enrollment target

NCT02247960 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 175 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02247960, a NA study, was terminated before completion, sponsored by University of Rochester.

TERMINATED
Registry status
NA
Development phase
175 participants
Enrollment target

Study Summary

The aim of this study is to determine whether antibiotics prophylaxis at the time of urinary catheter removal decreases the number of symptomatic urinary tract infections in patients after radical prostatectomy. In addition, the investigators aim to determine whether antibiotic prophylaxis is potentially harmful to patients (e.g. adverse reactions from antibiotic use, resistant bacteria in the urine, Clostridium difficile infections etc.). The investigators also aim to identify specific populations that may be at higher risk of developing urinary tract infections with urinary catheter use after radical prostatectomy.

Interventions

  • DRUG Ciprofloxacin

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2014-07
Est. Completion 2016-05
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT02247960

The ClinicalTrials.gov registry entry for NCT02247960 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Ciprofloxacin is the first listed.

NCT02247960 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02247960 about?

NCT02247960 is a clinical study titled "Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy". The aim of this study is to determine whether antibiotics prophylaxis at the time of urinary catheter removal decreases the number of symptomatic urinary tract infections in patients after radical prostatectomy. In addition, the investigators aim to determine whether antibiotic prophylaxis is potent...

What is the current status of trial NCT02247960?

This trial is currently terminated. It is a NA study. The enrollment target is 175 participants. The study started on 2014-07. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02247960?

The interventions under investigation include: Ciprofloxacin (DRUG).

Who is sponsoring clinical trial NCT02247960?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.